The landscape of metabolic research is shifting rapidly. For years, Semaglutide has been the undisputed leader in peptide-based weight management. However, a new contender known as Retatrutide—nicknamed the "Triple G"—is producing clinical results that have researchers calling it a "bariatric surgery in a bottle."
If you are evaluating these two molecules for your next research…